Yahoo
NasdaqCM - Nasdaq Real Time Price USD

KALA BIO, Inc. (KALA)

0.1655 -0.0096 (-5.48%)
At close: October 30 at 4:00:00 PM EDT
0.1763 +0.0108 (+6.53%)
After hours: October 30 at 7:58:54 PM EDT

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Ms. Mary Reumuth CPA
Treasurer & Secretary 1.01M -- 1975
Mr. Avi Minkowitz
CEO, CFO & Chairman -- -- 1988
Dr. Justin Hanes Ph.D.
Founder & Chair of the Scientific Advisory Board -- -- --
Ms. Jill S. Steier
Executive Director of Investor Relations & Corporate Communications -- -- --
Mr. Vincent Kosewski
Senior VP of Manufacturing & Supply Chain Management -- -- 1963
Dr. Francis S. Mah M.D.
Chief Medical Advisor -- -- --
Mr. Josiah Craver CPA
Senior VP & Corporate Controller -- -- --
Mr. Carl Rennie
Executive Director of Account Management -- -- --
Mr. Patrick Bedell
Executive Director of Trade & Alternate Channels -- -- --

KALA BIO, Inc.

1167 Massachusetts Avenue
Arlington, MA 02476
United States
781 996 5252 https://www.kalarx.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
6

Description

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Corporate Governance

KALA BIO, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 24, 2026 at 12:00 AM UTC

DEF 14A: Proxy Statements

September 11, 2026 at 12:00 AM UTC

PRE 14A: Proxy Statements

September 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 9, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 28, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 19, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 14, 2026 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

July 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 12, 2026 at 12:00 AM UTC

S-3/A: Offering Registrations

May 15, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: